Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
Human respiratory syncytial virus (HRSV) is the leading cause of bronchiolitis and pneumonia in infants, children, the elderly and the immune-compromised. The goal of immunization is to provide sufficient protection to prevent serious lower respiratory tract diseases leading to hospitalization and r...
Saved in:
Main Author: | Jalilian, Farid Azizi |
---|---|
Format: | Thesis |
Language: | English English |
Published: |
2011
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/19448/1/FBSB_2011_3_F.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
by: Suhaimi, Siti Syazani
Published: (2011) -
A study of children with respiratory syncytial virus (RSV) infection admitted to sabah women and children's Hospital (SWACH) Kota Kinabalu, Sabah /
by: Chia, Kelvin Cheong Yung
Published: (2013) -
Genotypic and phenotypic differences in respiratory syncytial virus subtypes A and B /
by: Khor, Chee Sieng -
Investigating the role of autophagy in regulating innate cytokine response of human lung epithelial cells to respiratory syncytial virus
by: Azman, Nur Amiera Fatin
Published: (2021) -
Respiratory syncytial virus chest infection in University Hospital, Kuala Lumpur /
by: Chan, Patrick Wai Kiong
Published: (1997)